Curb on seniors’ drugs protested
New rules proposed by the Obama administration to limit the array of antidepressants and other prescription drugs currently available to millions of seniors have set off an intense round of lobbying by patient advocates clamoring to preserve access and by pharmaceutical companies eager to preserve profits. Under the proposed guidelines for Medicare prescription drug benefits, seniors who currently have access to about 57 antidepressants and anti-psychotics could see their choices dwindle to 15, according to a pharmaceutical industry-backed group...Read More
Notice: The “Read more…” link provided above connects readers to the full text of the posted article. The URL (internet address) for this link is valid on the posted date; socialsecurityreport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc., the AMAC Foundation, or socialsecurityreport.org.